Review of my Portfolio (31/08/2025)
Total unrealized profit: + 33.4%
YTD performance: +8.4%
# Returns exclude dividend
Benchmark S&P500 YTD: + 10.08%


Added in August
Goal 1: ( $ 67,643.28 / $ 80,464) ⚔️
Growth Portfolio: -
Dividend Portfolio: U11, HMN, ME8U, C38U, C2PU, OV8, O39, United Global Durable Equities
Portfolio Weightage

Dividend Recieved
Goal 2: ($ 12, 401.49 / $ 17,117) ❤️
Dividend recieved in August = $ 3,263.79

US Market Review
- S&P500 marking its fourth consecutive monthly gain and market is now greedy.
- For worst case, I am anticipating a pull-back to ~$566 for $SPY, a 10 to 12% drop.
- The first support and buy point will be at ~$630.
- Historically, September will be a negative month and may be a good buying opportunity.


Sectors
- Currently, $XLK, $XLY and $XLC are in trend with the index. Thus there are no advantage in buying into individual sectors now.
- $XLV (healthcare) is still in consolidation. May still add more as long price below $140 but cautious not to be over-concentrated.
- Healthcare is a slow-to-moderate grower but defensive. it helps to cushion overall portfolio volatility but unlikely to lead a bull market. It is just my temporary parking position.

Individual Stock
- MSFT & META have retrace to it's 50 SMA, but is still generally considered expensive.
- MSFT: intrinsic value = $320 (overvalued)
1st support ~$506
2nd support ~$478
3rd support ~$430
- META: intrinsic value = $685 (overvalued)
1st support ~$735
2nd support ~$680
3rd support ~$575
- The other Magnificent 3 intrinsic value, but still far from their technical support.
- GOOGL: Intrinsic value = $215 (fair valued)
- AMZN: Intrinsic value = $267 (undervalued)
- AAPL: Intrinsic value= $216 (overvalued)


Conclusions
- There are not much discount at US market in August.
- Anticipating a retracement in September, looking to add some AMZN or GOOGL if the technical setup is correct.
- As the index is still overextended, I believe individual stocks still have some room to fall as they are highly correlated.